KP673
- Generic Name
- KP673
A Study of ZN-e4 in Subjects With Epidermal Growth Factor Receptor Mutated Non-Small Cell Lung Cancer
- First Posted Date
- 2018-02-26
- Last Posted Date
- 2024-01-25
- Lead Sponsor
- Zeno Pharmaceuticals, Inc.
- Target Recruit Count
- 34
- Registration Number
- NCT03446417
- Locations
- 🇧🇦
Site 8, Banja Luka, Bosnia and Herzegovina
🇧🇦Site 7, Sarajevo, Bosnia and Herzegovina
🇺🇸Site 5, Detroit, Michigan, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath